Abstract: A polymorphic network control system and a polymorphic network control system method supporting terminal mobile access. A network architecture is redesigned based on the idea of separation of an identifier from a locator. In this network mode, the three-layer protocol is no longer a traditional IP message, but a message carrying a locator and an identifier. The polymorphic SDN network controller is responsible for forwarding the data packet to a destination corresponding to a destination locator. When the network location of a mobile device is changed, the transmission connection established based on the identifier will suspend communication due to the disconnection of the physical link. When the mobile device is re-accessed and a new forwarding path is established, the transmission connection can recover communication.

Abstract: A polymorphic network control system and a polymorphic network control system method supporting terminal mobile access. A network architecture is redesigned based on the idea of separation of an identifier from a locator. In this network mode, the three-layer protocol is no longer a traditional IP message, but a message carrying a locator and an identifier. The polymorphic SDN network controller is responsible for forwarding the data packet to a destination corresponding to a destination locator. When the network location of a mobile device is changed, the transmission connection established based on the identifier will suspend communication due to the disconnection of the physical link. When the mobile device is re-accessed and a new forwarding path is established, the transmission connection can recover communication.

Abstract: The present disclosure discloses a spacer tube reverse osmosis (STRO) membrane and a preparation method thereof, which relates to the technical field of reverse osmosis membranes. The preparation method of the STRO membrane specifically comprises the following steps: S101: preparation of a zirconia sol; S102: preparation of a casting solution; S103: preparation of a polysulfone ultrafiltration membrane; S104: immersion; and S105: coating. In the preparation method of the present disclosure, an ionic liquid and high-pressure-resistant particles are introduced into an ultrafiltration layer, the ionic liquid is cross-linked with the ultrafiltration layer in the process of interfacial polymerization, and a layer of the ionic liquid is coated on a surface, so that a three-layer high-performance three-dimensional crosslinking system is formed via the ionic liquid.

Abstract: Wolfberry glycopeptide composition and methods for preparing and using the same, the part with a molecular weight distribution of 1000 Da to 10000 Da of the wolfberry glycopeptide accounts for 50-85% on the HPLC differential refractive index map; and the protein content is 20-35% weight percentage, neutral polysaccharide content is 20-35% weight percentage. Optionally, the uronic acid content is 5-20% weight percentage. The preparation method of the present invention removes part of insoluble impurities by a heating flocculation method, instead of the conventional organic solvent extraction process, and without using any organic solvents in the whole process.

Abstract: The invention provides a compound of formula (I): or a salt thereof, wherein R1-R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as RNA polymerase inhibitors and antibacterial agents.

Abstract: Wolfberry glycopeptide composition and methods for preparing and using the same, the part with a molecular weight distribution of 1000 Da to 10000 Da of the wolfberry glycopeptide accounts for 50-85% on the HPLC differential refractive index map; and the protein content is 20-35% weight percentage, neutral polysaccharide content is 20-35% weight percentage. Optionally, the uronic acid content is 5-20% weight percentage. The preparation method of the present invention removes part of insoluble impurities by a heating flocculation method, instead of the conventional organic solvent extraction process, and without using any organic solvents in the whole process.

Abstract: The invention provides compounds that are inhibitors of bacterial RNA polymerase. The invention also provides compositions comprising such compounds, methods of making such compounds, and methods of using said compounds. The invention has applications in control of bacterial gene expression, control of bacterial growth, antibacterial chemistry, and antibacterial therapy.

Abstract: The invention provides compounds that are inhibitors of bacterial RNA polymerase. The invention also provides compositions comprising such compounds, methods of making such compounds, and methods of using said compounds. The invention has applications in control of bacterial gene expression, control of bacterial growth, antibacterial chemistry, and antibacterial therapy.

Abstract: The present invention relates to methods and compositions for treating and/or preventing a disease or disorder associated with abnormally high level of the IFP35 family of proteins, including IFP35 and NMI, methods and compositions for diagnosis, prognosis or treatment monitoring of a disease or disorder associated with abnormally high level of the IFP35 family of proteins, including IFP35 and NMI, and methods and compositions for identifying a modulator of the IFP35 family of proteins, including IFP35 and NMI.

Abstract: A beverage dispenser capable of preparing a variety of alternative types of beverages using different brewing parameters depending on the type of beverage. In one embodiment, the beverage dispenser is configured to use temperature, pressure and time parameters selected to provide optimal extraction for the type of beverage being prepared. In one embodiment, the beverage dispenser is intended to brew a variety of herbal teas with ingredients selected in accordance with traditional Chinese medicine. In one embodiment, the particle sizes of the various TCM ingredients are selected to provide optimized extraction in the beverage dispenser. The beverage dispenser may be configured to identify the type of beverage pod installed in the system and automatically prepare that beverage in accordance with optimized brewing parameters determined based on the ingredients and the particle sizes of those ingredients. The beverage dispenser may be capable of collecting user information and providing beverage recommendations.

Abstract: The invention provides compounds of formula Ia, Ib and Ic: and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

Abstract: The invention provides a compound of formula I: or a salt thereof, wherein R1-R3 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antibacterial agents.

Abstract: The invention provides compounds of formula Ia, Ib and Ic: and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

Abstract: The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

Abstract: A method and a device for establishing an information communication network system structure, as well as a server and a router. The method includes the steps of after establishing an initial service route, utilizing the server to periodically acquire current network resource configuration information and flow rate state information transmitted by each router node, and generating network resource view and network flow rate view; utilizing the server to acquire current real transmission performance of the initial service route according to the network resource view and the network flow rate view; including current real transmission performance and current business transmission requirement, and generating a reconstruction order when current real transmission performance does not match current business transmission requirement.

Abstract: The invention provides compounds of formula la, lb and Ic: [Formula Ia, Ib, and Ic] and salts thereof, wherein variables are as described in the specification, as well as compositions comprising a compound of formula Ia-Ic, methods of making such compounds, and methods of using such compounds, e.g., as inhibitors of bacterial RNA polymerase and as antibacterial agents.

Abstract: A method and a device for establishing an information communication network system structure, as well as a server and a router. The method includes the steps of after establishing an initial service route, utilizing the server to periodically acquire current network resource configuration information and flow rate state information transmitted by each router node, and generating network resource view and network flow rate view; utilizing the server to acquire current real transmission performance of the initial service route according to the network resource view and the network flow rate view; including current real transmission performance and current business transmission requirement, and generating a reconstruction order when current real transmission performance does not match current business transmission requirement.

Abstract: The invention provides a compound of formula I: or a salt thereof, wherein R1-R3 have any of the values described in the specification, as well as compositions comprising a compound of formula I. The compounds are useful as antibacterial agents.

Abstract: The invention provides a compound of formula (I): or a salt thereof, wherein R1-R5 have any of the values described in the specification, as well as compositions comprising a compound of formula (I). The compounds are useful as RNA polymerase inhibitors and antibacterial agents.

Abstract: The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumors, such as acute leukemia, chronic leukemia, multiple myeloma and lymphoma, solid tumors, such as liver cancer, rectal cancer, mammary cancer and esophagus cancer, and skin disorders, such as psoriasis and acne.